Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors – AARD

Pomerantz LLP announced a securities class action lawsuit against Aardvark Therapeutics (NASDAQ: AARD) and certain officers and directors. The notice provides no allegations, damages, class period, or operating details, but the litigation creates a reputational and potential financial overhang for the biotech company.